Tavakoli PS, Eadie LN, Heatley SL, White DL The dual SYK/JAK inhibitor cerdulatinib demonstrates in vitro efficacy against a novel MYB-TYK2 fusion protein in acute lymphoblastic leukaemia cells Invited Oral Presentation Adelaide, South Australia
Period
31 Jul 2019
Event title
Cancer in SA Translational Research Meeting, SAHMRI